What's New?

March 31, 2015
Health Canada Information Update

Health Canada releases an information update entitled “ADHD drugs may increase risk of suicidal thoughts and behaviours in some people; benefits still outweigh risks”.

Health Canada has just released an information update stating that clearer warnings about risk of suicidal thoughts and behaviours will be included in the prescribing information for all ADHD medications:

Previously this warning was only included on Strattera (Atomoxetine). It is very important to read the updated information thoroughly and pay attention to the specific language used by Health Canada. Health Canada states that there is little evidence that ADHD medications cause suicidal thoughts and behaviours, but that they may possibly contribute to the risk. Health Canada has not shared what triggered the update at this time other than saying there have been some reports. Since ADHD in itself increases the risk of suicidal ideation and behaviours physicians treating patients with ADHD are already aware that monitoring for these symptoms is important. Additionally, ADHD can commonly occur along with other disorders such as depression and bipolar, so physicians are aware that additional disorders such as these need to be screened for during the assessment process.  However, an added reminder to physicians, caregivers and adults taking the medication to monitor for changes in mood, thoughts, feelings of depression and suicidal behaviour especially when medication is started, increased or even stopped seems to be a sensible suggestion.

Awareness of potential side effects, even when the risk is minimal is important, but should not lead to panic or stopping the medication. Health Canada has also stated very clearly that the benefits of medications for ADHD still continue to outweigh the risks. Parents of children taking medication for ADHD and adults taking the medication should not be alarmed by this warning and they should not take their children off the medication especially without first speaking with their physician. If any of these symptoms are present caregivers and adults should be reporting these to their physician immediately. Treating any medical disorder with medication is always a matter of assessing the risk benefit ratio. Physicians follow this practice when prescribing medications. Every medication has a risk of side effects, but not treating ADHD also has significant side effects. If you have concerns speak to your physician. 

March 26, 2015

2014 CADDAC Accomplishments

CADDAC would like to share our 2014 accomplishments with you. Feel free to forward this link to others who may have an interest in ADHD. We encourage you to support more great work in 2015 by joining the CADDAC family of members!

View our 2014 Accomplishments

March 23, 2015

ADHD Prep (Parent Readiness Education Program)

CADDAC presents ADHD PREP, a 2-day program on Saturday April 25 from 9AM - 4PM and Sunday April 26 9AM - 4PM

Visit the ADHD Prep Outline for an overview of the course content.

ADHD PREP is a comprehensive 12­-hour program geared to parents of newly diagnosed children and adolescents with ADHD, and to parents wishing to upgrade their knowledge on the more complex aspects of ADHD including ADHD and learning, executive functioning and self and mood regulation.

Treatment options, parenting strategies and advocacy skills will also be covered. The program will occur over a weekend allowing parents from outside the local area to drive in for the weekend. Pricing includes workshop materials and light refreshments each morning and afternoon.

February 25, 2015
New Survey on Generic Medications

A group of national and provincial organizations who work with, and represent individuals and families living with a wide range of mental health conditions responding to concerns raised by our clients, members and constituents/stakeholders, came together to gain better insight into their experiences with medications.To better understand direct experiences with medications, we have launched a nation-wide survey requesting feedback from individuals, caregivers and healthcare providers on existing knowledge and experience with brand name and generic medications.

Patients and caregivers
are invited to complete the survey posted at https://www.surveymonkey.com/s/FKC8YFB.
Clinicians are asked to complete the survey at https://www.surveymonkey.com/s/MFLJWFV.

The survey will be available online until April 15th, 2015.

After the survey results have been analyzed a paper will be written and shared. Without awareness and knowledge patients, their caregivers and their prescribing physicians cannot make informed decisions about treatment options.
Thank you in advance for your help with this survey!

Public Service Announcement featuring Rick Green.


Broadcast Quality Link for Media
NOTE: Due to the high bit rate this version will not run normally on many consumer computers. It is for broadcast purposes.

NEW Adult ADHD Information USB

Join us on:
ADHD Awareness Web site
ADHD Awareness Facebook Page

Privacy Policy  Terms of Use